Celia Fdez. Rubio

Lecturer

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Celia Fdez. Rubio is a Lecturer at Universidad de Navarra in Spain. Her research focuses on parasitology, particularly in relation to leishmaniasis and Chagas disease. Recent publications include studies on BRCT domain roles in Leishmania major pathogenesis and the development of novel therapeutic targets for infections. She is actively involved in exploring antimicrobial peptides and their applications in treating neglected zoonotic diseases.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

SPAIN

View details

Paul A. Nguewa

Universidad de Navarra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Celia Fdez. Rubio

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The Role of BRCT Domain from LmjPES in Leishmania major Pathogenesis

Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression

Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals

BRCT Domains: Structure, Functions, and Implications in Disease—New Therapeutic Targets for Innovative Drug Discovery against Infections

Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells

In <i>Leishmania major</i>, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity

Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis

Potential therapeutic targets shared between leishmaniasis and cancer.

Potential therapeutic targets shared between leishmaniasis and cancer

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome

Collaborators (6)

Esther Larrea

JAVIER CARRION

Silvia Perez-Silanes

Esther Moreno Amatria

Guillermo Martinez-de-Tejada

Paul A. Nguewa

Make your next move.